Aguis-invest19 Feb 2013 07:26
The phase 1 results where astonishing, given in Dec with a recent 1/2 year results update confirming the current phase 2 trial is on target. The company is for sale with a platform and 5 vaccines for cancer. with SCIb1 providing the testing ground for the platform. The PYM result can not be repeated in SCLP as clinial benefit has been observed.